GlassScriptPhysician profile
Theodore Schafer
NPI 1609851591
$2,661.90
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $382 · 2021: $1,464 · 2022: $61.91 · 2023: $252 · 2024: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $559.32 | 2019-2024 | Linzess, Creon, Viberzi |
| Braintree Laboratories, INC. | $514.43 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $464.70 | 2019-2024 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $368.50 | 2019-2023 | Entyvio |
| Celgene Corporation | $152.86 | 2021 | |
| Janssen Biotech, INC. | $91.08 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $89.31 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $74.88 | 2019-2020 | |
| Pfizer INC. | $50.03 | 2021-2024 | |
| Intercept Pharmaceuticals, INC. | $41.32 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $37.39 | 2019-2020 | |
| Covidien LP | $34.71 | 2020 | |
| Nestle Healthcare Nutrition INC. | $32.88 | 2021 | |
| Gilead Sciences, INC. | $31.12 | 2023 | |
| Ardelyx, INC. | $23.05 | 2024 | Ibsrela |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $22.82 | 2024 | |
| Organon LLC | $21.61 | 2023 | Renflexis, Hadlima |
| Redhill Biopharma INC. | $21.09 | 2021 | |
| Alfasigma USA, INC. | $17.72 | 2020 | |
| Ucb, INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Schafer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.